Tissue biocompatibility of new biodegradable drug-eluting stent materials

Journal of Materials Science: Materials in Medicine

Volumn 18, Issue 8, 2007, Pages 1543-1547

  Uurto, Ilkka ^a,b   Kotsar, Andres ^b   Isotalo, Taina ^c   Mikkonen, Joonas ^d   Martikainen, Paula M ^b   Kellomäki, Minna ^d   Törmälä, Pertti ^d   Tammela, Teuvo L J ^b   Talja, Martti ^c   Salenius, Juha Pekka ^b  

^a SATAKUNTA CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; DISEASES; DRUG PRODUCTS; MEDICAL PROBLEMS; TISSUE ENGINEERING;

DRUG-ELUTING BIODEGRADABLE STENTS; OPERATIVE TRAUMA; ORGANOTIN-POSITIVE POLYVINYLCHLORIDE;

MATERIALS SCIENCE;

DEXAMETHASONE; INDOMETACIN; ORGANOTIN COMPOUND; POLYLACTIC ACID; POLYVINYLCHLORIDE; SILICON;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABLE IMPLANT; CONTROLLED STUDY; DRUG ELUTING STENT; IN VIVO STUDY; MALE; MUSCLE; NECROSIS; NEGATIVE FEEDBACK; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; RABBIT;

ABSORBABLE IMPLANTS; ANIMALS; ANTI-INFLAMMATORY AGENTS; DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; EQUIPMENT FAILURE ANALYSIS; INDOMETHACIN; LACTIC ACID; MALE; MATERIALS TESTING; MUSCLE, SKELETAL; MYOSITIS; POLYMERS; RABBITS; STENTS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 34447101156     PISSN: 09574530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10856-007-3060-3     Document Type: Article

References (28)

1. M. R. BENNET, Coron. Dis. 89 (2003) 218
2. S. T. LAROIA and A. T. LAROIA, Cardiol. Rev. 12(1) (2004) 37
3. M. C. MORICE et al., N. Engl. J. Med. 346(23) (2002) 1773
4. A. COLOMBO et al., Circulation 108 (2003) 788
5. M. TALJA et al., J. Endourol. 11 (1997) 1
6. D. E. CUTRIGHT et al., Oral. Surg. 37 (1974) 142
7. P. TÖRMÄLÄ, Clin. Mater. 10 (1992) 29
8. T. Välimaa and P. Törmälä, 1998, Stenting the urinary system (Oxford: Isis Medical Media Ltd), p. 53
9. T. VÄLIMAA and S. LAAKSOVIRTA, Biomaterials 25 (2004) 1225
10. H. TAMAI et al., Circulation 102(4) (2000) 399
11. T. ISOTALO et al., J. Urol. 160 (1998) 2033
12. T. ISOTALO et al., J. Endourol. 16 (2002) 759
13. M. TALJA et al., J. Urol. 154 (1995) 2089
14. A. PETAS et al., J. Urol. 157 (1997) 173
15. A. Petas et al., Br. J. Urol. 80 (1997) 439
16. K. TSUJI et al., Int. J. Cardiovasc. Interv. 5(1) (2003) 13
17. Biological evaluation of medical devices. Part 6. Tests for local effects after implantation (1994) ISO 10993-6
18. Biological evaluation of medical devices. Part 5. Tests for in vitro cytotoxicity, 1999, ISO 10993-5
19. I. UURTO et al., J Endovasc Therapy. 10 (2003) 1110
20. Biological evaluation of medical devices. Part 1. Evaluation and testing, 2003, ISO 10993-1
21. T. ISOTALO et al., Urol. Res. 27 (1999) 149
22. T. ISOTALO et al., J. Endourol. 13(7) 1999 525
23. G. BROOKS et al., J. Pharm. Pharmacol. 55 (2003) 519
24. E. P. STRECKER et al., Cardiovasc. Interv. Radiol. 21(6) (1998) 487
25. A. M. LINCOFF et al., J. Am. Coll. Cardiol. 29(4) (1997) 808
26. X. LIU et al., Catheter. Cardiovasc. Interv. 60(2) (2003) 172
27. Biological evaluation of medical devices. Part 12. Sample preparation and reference material, 2002, ISO 10993-12
28. S. LAAKSOVIRTA et al., J. Urol. 167 (2002) 1527